Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cytek Biosciences Inc

8EQ
Current price
6 EUR +0.05 EUR (+0.84%)
Last closed 6.42 USD
ISIN US23285D1090
Sector Healthcare
Industry Medical Devices
Exchange Frankfurt Exchange
Capitalization 908 117 568 USD
Yield for 12 month +1.36 %
1Y
3Y
5Y
10Y
15Y
8EQ
21.11.2021 - 28.11.2021

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California. Address: 47215 Lakeview Boulevard, Fremont, CA, United States, 94538

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.1 USD

P/E ratio

Dividend Yield

Current Year

+193 015 000 USD

Last Year

+164 036 000 USD

Current Quarter

+51 500 000 USD

Last Quarter

+46 617 000 USD

Current Year

+109 426 000 USD

Last Year

+100 974 000 USD

Current Quarter

+29 005 000 USD

Last Quarter

+25 436 000 USD

Key Figures 8EQ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -15 157 000 USD
Operating Margin TTM -8.25 %
PE Ratio
Return On Assets TTM -2.74 %
PEG Ratio
Return On Equity TTM -2.54 %
Wall Street Target Price 8.1 USD
Revenue TTM 201 210 000 USD
Book Value 2.97 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 7.3 %
Dividend Yield
Gross Profit TTM 100 974 000 USD
Earnings per share -0.08 USD
Diluted Eps TTM -0.08 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 65.8 %
Profit Margin -5.05 %

Dividend Analytics 8EQ

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 8EQ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 8EQ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 370.3704
Enterprise Value Revenue 3.1985
Price Sales TTM 4.5133
Enterprise Value EBITDA -133.9621
Price Book MRQ 2.3526

Financials 8EQ

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 8EQ

For 52 weeks

4.66 USD 9.87 USD
50 Day MA 5.29 USD
Shares Short Prior Month 4 304 253
200 Day MA 6.17 USD
Short Ratio 7.14
Shares Short 4 474 407
Short Percent 4.36 %